Pharmaceutical

TG Therapeutics to Participate in the Evercore HealthCONx Conference

Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ETNEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TG…

4 weeks ago

Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset

Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset Research presented at…

4 weeks ago

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)…

4 weeks ago

Rakovina Therapeutics Announces Private Placement Offering

The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov.…

4 weeks ago

Theralase(R) Release’s 3Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")…

4 weeks ago

Dental Practice Management Market Surges to USD 5.73 Billion by 2030, Propelled by 10.9% CAGR – Verified Market Reports®

The dental practice management market is driven by the increasing prevalence of oral health issues, a growing demand for cosmetic…

4 weeks ago

ChemAI: AI-Driven Digital Chemistry Pioneer announces Strategic Rebrand and Key Board Appointments

LEEDS, England, Nov. 27, 2024 /PRNewswire/ -- Deepmatter, a leading innovator in digital chemistry, today unveils its rebrand to ChemAI, as part…

4 weeks ago

Teva Launches Vital Medicines Program in El Salvador for Underserved Communities

NORTHAMPTON, MA / ACCESSWIRE / November 27, 2024 / Teva PharmaceuticalTeva is pleased to announce the launch of a new…

4 weeks ago

SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers

- Preselection Method for Cancers Responding to SLS009: High Efficacy of SLS009 Observed in 67% of ASXL1 Mutated Solid Cancers…

4 weeks ago

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

Webinar being held today "Evolving strategic context for phages, Introducing new opportunities" to present PHAXIAM Therapeutics strategyBased on the positive…

4 weeks ago